Nos webinaires
Introduction to Skin Delivery with Lipid Excipients
Delivering drug molecules to and through the skin results from the complex interplay between active pharmaceutical ingredient, skin condition and vehicle. This webinar aims at giving an overview on skin delivery and clues to select the appropriate excipients for efficient skin drug delivery.
What Makes Lipid Excipients so Special? Overcoming Bioavailability Challenges and Accelerating Development Using Softgels
Hear Catalent and Gattefossé experts explain how lipid drug development platforms can meet the need for speed to clinic and how innovative lipid excipients and technologies could solve formulation challenges, optimize bioavailability, improve patient compliance, and bring products faster to market.
Sustained Release Lipid formulations: Scope on Single & Dual matrices
Understanding the advantages and versatility of using Lipid Excipients for developing Sustained Release Dosage forms. Part II: learn how to formulate lipid -only and lipid/polymer SR matrices. Speaker: Dr. Namita Desai, Associate Professor, C.U. Shah College of Pharmacy, India
Lipid excipients: smart solution for sustained release formulations
Understanding the advantages and versatility of using Lipid Excipients for developing Sustained Release Dosage forms. Part I: focus on lipid excipients and their advantages in sustained release formulations. Speaker: Dr. Ketkee Deshmukh, Regional Technical Manager N.India & Nepal, Gattefosse India
Where Do We Stand for Poorly Soluble Drugs and Peptides in Oral Delivery
Speaker: Inayet Ellis of Gattefossé USA and Chris Moreton of FinBrit Consulting
Lipid Excipients for Solubility and Bioavailability Enhancement
Speaker: Dr. Agnivesh Shrivastava, Regional Technical Manager – South India & Nepal, Gattefosse India Pvt. Ltd. The talk covered application of lipid excipients in solubility and bioavailability enhancement of poorly water soluble drugs i.e. BCS Class II and IV.
3D printing to develop solid lipid-based formulations
The use of three-dimensional printing (3DP) in the development of pharmaceutical dose forms is growing rapidly. However, the studies are exclusively focused on polymer-based systems and very little is known on 3DP for lipid-based formulations. Thus, 3DP was implemented to explore the feasibility of 3DP technology for the development of solid lipid-based formulations.
Strategies for cannabinoids for topical formulations
This webinar will focus on topical dosage forms containing cannabinoids. Practical tips will be given for successful formulation of these highly lipophilic, sensitive active ingredients. Speaker: Ana Gutierrez, Technical Support Manager - Pharmaceuticals Gattefossé SAS
Evidence-based approach for optimizing lipid-based drug delivery systems for oral peptide delivery: Part 2 SEDDS & SMEDDS
In this second part of the presentation Camille explains the rational for using lipid excipients in SEDDS/SMEDDS for the oral delivery of peptides, what features of the formulation are important to protect peptides from degradation in vivo and promote absorption. Speaker: Camille Dumont, PhD, Formulation Scientist
